Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Novartis
Boehringer Ingelheim
Accenture
Daiichi Sankyo
QuintilesIMS
Mallinckrodt
Moodys
Covington
Medtronic

Generated: January 17, 2018

DrugPatentWatch Database Preview

Amag Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AMAG PHARMS INC, and what generic alternatives to AMAG PHARMS INC drugs are available?

AMAG PHARMS INC has four approved drugs.

There are nine US patents protecting AMAG PHARMS INC drugs on AMAG PHARMS INC drugs in the past three years.

There are fifty-nine patent family members on AMAG PHARMS INC drugs in thirty-four countries and six supplementary protection certificates in five countries.

Summary for Amag Pharms Inc
International Patents:59
US Patents:9
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Amag Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Amag Pharms Inc INTRAROSA prasterone INSERT;VAGINAL 208470-001 Nov 16, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amag Pharms Inc INTRAROSA prasterone INSERT;VAGINAL 208470-001 Nov 16, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Amag Pharms Inc INTRAROSA prasterone INSERT;VAGINAL 208470-001 Nov 16, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Amag Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996 ➤ Subscribe ➤ Subscribe
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for AMAG PHARMS INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 30 mg/mL, 17 mL single-use vials ➤ Subscribe 12/4/2015

Non-Orange Book US Patents for Amag Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,555,133 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Amag Pharms Inc Drugs

Supplementary Protection Certificates for Amag Pharms Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00558 Netherlands ➤ Subscribe PRODUCT NAME: FERUMOXYTOL IN IEDERE DOOR HET BASISOCTROOI BESCHERMDE VORM; REGISTRATION NO/DATE: EU/1/12/774/001-002 20120615
1169062/01 Switzerland ➤ Subscribe PRODUCT NAME: FERUMOXYTOL; REGISTRATION NO/DATE: SWISSMEDIC 62033 17.08.2012
2012 00050 Denmark ➤ Subscribe
90043-7 Sweden ➤ Subscribe PRODUCT NAME: FERUMOXYTOL; REG. NO/DATE: EU/1/12/774/001 20120615
0558 Netherlands ➤ Subscribe PRODUCT NAME: FERUMOXYTOL IN IEDERE DOOR HET BASISOCTROOI BESCHERMDE VORM; REGISTRATION NO/DATE: EU/1/12/774/001-002 20120615
114 Luxembourg ➤ Subscribe PRODUCT NAME: FERUMOXYTOL
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cerilliant
Argus Health
Chubb
Fish and Richardson
Medtronic
Cantor Fitzgerald
McKinsey
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot